AAAAAA
Results: 1-25/26
Authors:
Bull, U
Schober, O
Osieka, R
Citation: U. Bull et al., Advances in surgery - Without advances in medical technology?, DEUT MED WO, 126(42), 2001, pp. 1188-1189
Authors:
Schafer, WM
Nowak, B
Kaiser, HJ
Black, S
Koch, KC
vom Dahl, J
Bull, U
Citation: Wm. Schafer et al., An approach for comparative quantification of myocardial blood flow (O-15-H2O-PET), perfusion (Tc-99m-tetrofosmin-SPECT), and metabolism (F-18-FDG-PET), NUKLEARMED, 40(5), 2001, pp. 164-171
Authors:
Reinartz, P
Schirp, U
Zimny, M
Sabri, O
Nowak, B
Schafer, W
Cremerius, U
Bull, U
Citation: P. Reinartz et al., Optimizing ventilation-perfusion lung scintigraphy: Parting with planar imaging, NUKLEARMED, 40(2), 2001, pp. 38-43
Authors:
Sabri, O
Zimny, M
Schreckenberger, M
Reinartz, P
Nowak, B
Ostwald, E
Schafer, W
Block, S
Setani, K
Bull, U
Citation: O. Sabri et al., Characterization of radioiodine therapy failures in Graves' disease, NUKLEARMED, 40(1), 2001, pp. 1-6
Authors:
Cremerius, U
Fabry, U
Neuerburg, J
Zimny, M
Bares, R
Osieka, R
Bull, U
Citation: U. Cremerius et al., Prognostic significance of positron emission tomography using fluorine-18-fluorodeoxyglucose in patients treated for malignant lymphoma, NUKLEARMED, 40(1), 2001, pp. 23-30
Authors:
Di Martino, E
Nowak, B
Krombach, GA
Seilhaus, B
Hausmann, R
Cremerius, U
Bull, U
Westhofen, M
Citation: E. Di Martino et al., Results of pretherapeutic lymph node diagnosis in head and neck cancer: Clinical value of (18)-fluorodeoxyglucose positron emission tomography (PET)., LARY RH OTO, 79(4), 2000, pp. 201-206
Authors:
Bull, U
Reinartz, P
Citation: U. Bull et P. Reinartz, Quantification of skeletal scintigraphy with Tc-99m-labelled phosphonates:Determinants and reference points, NUKLEARMED, 39(5), 2000, pp. N69-N71
Authors:
Sabri, O
Bull, U
Citation: O. Sabri et U. Bull, Do thyrostatic agents reduce the success rate in radioiodide therapy? Response, NUKLEARMED, 39(2), 2000, pp. N26-N26
Authors:
Sabri, O
Hellwig, D
Schreckenberger, M
Schneider, R
Kaiser, HJ
Wagenknecht, G
Setani, K
Reinartz, P
Zimny, M
Mull, M
Ringelstein, EB
Bull, U
Citation: O. Sabri et al., One-year follow-up or neuropsychology, MRI, rCBF and glucose metabolism (rMRGlu) in cerebral microangiopathy, NUKLEARMED, 39(2), 2000, pp. 43-49
Authors:
Setani, K
Schreckenberger, M
Sabri, O
Meyer, PT
Zeggel, T
Bull, U
Citation: K. Setani et al., Comparison of different methods for attenuation correction in brain PET: Influence on the calculation of the metabolic glucose rate, NUKLEARMED, 39(2), 2000, pp. 50-55
Authors:
Bull, U
Bartenstein, P
Kirsch, CM
Schicha, H
Citation: U. Bull et al., Combined systems for SPECT, coincidence, PET and CT - Technical spectrum, operation requirements and possible applications, NUKLEARMED, 39(1), 2000, pp. 3A-6A
Authors:
Nowak, B
Di Martino, E
Janicke, S
Cremerius, U
Adam, G
Zimny, M
Reinartz, P
Bull, U
Citation: B. Nowak et al., Diagnostic evaluation of malignant head and neck cancer by F-18-FDG PET compared to CT/MRI, NUKLEARMED, 38(8), 1999, pp. 312-318
Authors:
Ostwald, E
Sabri, O
Cremerius, U
Jakse, G
Bull, U
Citation: E. Ostwald et al., Follow-up bone scintigraphy and rhenium application during therapy of a prostate cancer, NUKLEARMED, 38(7), 1999, pp. 302-305
Authors:
Reinartz, P
Zimny, M
Cremerius, U
Sabri, O
Kaiser, HJ
Nowak, B
Bull, U
Citation: P. Reinartz et al., Quantification of repositioning errors in PET-studies through superposition of emission and transmission scan - A comparison between one-step and two-step acquisitions, NUKLEARMED, 38(6), 1999, pp. 192-198
Authors:
Sabri, O
Bull, U
Citation: O. Sabri et U. Bull, Do thyreostatic drugs reduce the success rate in radioactive iodine therapy?, NUKLEARMED, 38(4), 1999, pp. A3-A6
Authors:
Zimny, M
Kaiser, HJ
Cremerius, U
Sabri, O
Schreckenberger, M
Reinartz, P
Bull, U
Citation: M. Zimny et al., F-18-FDG positron imaging in oncological patients: Gamma camera coincidence detection versus dedicated PET, NUKLEARMED, 38(4), 1999, pp. 108-114
Authors:
Cremerius, U
Fabry, U
Kroll, U
Zimny, M
Neuerburg, J
Osieka, R
Bull, U
Citation: U. Cremerius et al., Clinical value of FDG-PET for therapy monitoring of malignant lymphoma - Results of a retrospective study in 72 patients, NUKLEARMED, 38(1), 1999, pp. 24-30
Authors:
Reinartz, P
Sabri, O
Kinzel, S
Zimny, M
Bachmann, T
Kupper, W
Bull, U
Citation: P. Reinartz et al., Radioiodine therapy in veterinary medicine: Treatment of hyperthyroidism in a cat, NUKLEARMED, 38(1), 1999, pp. 31-34
Authors:
Schroder, W
Zimny, M
Rudlowski, C
Bull, U
Rath, W
Citation: W. Schroder et al., The role of F-18-fluoro-deoxyglucose positron emission tomography (F-18-FDG PET) in diagnosis of ovarian cancer, INT J GYN C, 9(2), 1999, pp. 117-122
Authors:
Wagenknecht, G
Kaiser, HJ
Bull, U
Citation: G. Wagenknecht et al., Multimodal integration, correlation and fusion of morphology and function:methods and first clinical applications, ROFO-F RONT, 170(5), 1999, pp. 416-426
Authors:
Erkwoh, R
Sabri, O
Willmes, K
Steinmeyer, EM
Bull, U
Sass, H
Citation: R. Erkwoh et al., Active and remitted schizophrenia: psychopathological and regional cerebral blood flow findings, PSYCH RES-N, 90(1), 1999, pp. 17-30
Authors:
Gouzoulis-Mayfrank, E
Schreckenberger, M
Sabri, O
Arning, C
Thelen, B
Spitzer, M
Kovar, KA
Hermle, L
Bull, U
Sass, H
Citation: E. Gouzoulis-mayfrank et al., Neurometabolic effects of psilocybin, 3,4-methylenedioxyethylamphetamine (MDE) and d-methamphetamine in healthy volunteers - A double-blind, placebo-controlled PET study with [F-18]FDG, NEUROPSYCH, 20(6), 1999, pp. 565-581
Authors:
Erkwoh, R
Sabri, O
Willmes, K
Steinmeyer, EM
Bull, U
Sass, H
Citation: R. Erkwoh et al., Aspects of connectivity in schizophrenia: Introduction, F NEUR PSYC, 67(7), 1999, pp. 318-326
Authors:
Schleicher, UM
Dohmen, BM
Gripp, S
Bares, R
Bull, U
Citation: Um. Schleicher et al., Bone marrow recovery after irradiation of the spine, STRAH ONKOL, 175(8), 1999, pp. 374-377
Authors:
Schreckenberger, M
Gouzoulis-Mayfrank, E
Sabri, O
Arning, C
Tuttass, T
Schulz, G
Kaiser, HJ
Wagenknecht, G
Sass, H
Bull, U
Citation: M. Schreckenberger et al., Investigations on the effects of "Ecstasy" on cerebral glucose metabolism:an 18-FDG PET study, NUKLEARMED, 37(8), 1998, pp. 262-267